Jeffrey L Wade - Net Worth and Insider Trading
Jeffrey L Wade Net Worth
The estimated net worth of Jeffrey L Wade is at least $428,232 dollars as of 2024-05-25. Jeffrey L Wade is the President and CFO of Lexicon Pharmaceuticals Inc and owns about 264,341 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $428,232. Details can be seen in Jeffrey L Wade's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey L Wade has not made any transactions after 2023-09-14 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey L Wade
Jeffrey L Wade Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey L Wade owns 1 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of Jeffrey L Wade’s form 4 insider trades.
Insider Ownership Summary of Jeffrey L Wade
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2023-09-14 | EVP & Gen. Counsel |
Jeffrey L Wade Latest Holdings Summary
Jeffrey L Wade currently owns a total of 1 stock. Jeffrey L Wade owns 264,341 shares of Lexicon Pharmaceuticals Inc (LXRX) as of September 14, 2023, with a value of $428,232.
Latest Holdings of Jeffrey L Wade
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2023-09-14 | 264,341 | 1.62 | 428,232 |
Holding Weightings of Jeffrey L Wade
Jeffrey L Wade Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey L Wade has made a total of 2 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 10,000 shares on September 14, 2023, which cost Jeffrey L Wade around $13,800.
Insider Trading History of Jeffrey L Wade
- 1
Jeffrey L Wade Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey L Wade's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey L Wade is -22.71%. GuruFocus also compares Jeffrey L Wade's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey L Wade within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey L Wade's insider trading performs compared to the benchmark.
Performance of Jeffrey L Wade
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.97 | | | | | |
| Relative Return to S&P 500(%) | -5.71 | | | | | |
Jeffrey L Wade Ownership Network
Jeffrey L Wade Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
Jeffrey L Wade is the EVP & Gen. Counsel of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, Jeffrey L Wade made 2 insider transaction in Lexicon Pharmaceuticals Inc (LXRX) with a net purchase of 22,000. Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 16,000 shares made by Wendy Mcdermott , and a net purchase of 27,775,050 shares made by Artal International S.c.a. .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
Jeffrey L Wade Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey L Wade. You might contact Jeffrey L Wade via mailing address: 8800 Technology Forest Place, The Woodlands Tx 77381.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
